A randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage

BACKGROUND: Previous trials of intravenous immunoglobulin (IvIg) treatment of women with recurrent miscarriage (RM) have provided diverging results. This may be due to different inclusion criteria and suboptimal treatment protocols in some trials. METHODS: According to a computer-generated list, 58...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Human reproduction (Oxford) 2002-03, Vol.17 (3), p.809-816
Hauptverfasser:	Christiansen, Ole B., Pedersen, Bjørn, Rosgaard, Anni, Husth, Merete
Format:	Artikel
Sprache:	eng
Schlagworte:	abortion Abortion, Habitual - epidemiology Abortion, Habitual - etiology Abortion, Habitual - genetics Abortion, Habitual - prevention & control Adult Biological and medical sciences Birth Rate Double-Blind Method Female Fetus - physiology Follow-Up Studies Genital system. Reproduction HLA-DR Humans HY antigen Immunoglobulins, Intravenous - therapeutic use intravenous immunoglobulin Karyotyping Male Medical sciences Pharmacology. Drug treatments Placebos Pregnancy recurrent spontaneous abortion Sex Ratio
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!